Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium. - Wikidata - wikimedia - TriplyDB

Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium.

Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium.

http://www.wikidata.org/entity/Q34116507

about

Phage therapy: concept to cure The promise of bacteriophage therapy for Burkholderia cepacia complex respiratory infections Bacteriophage T4 Genome Diagnostic and therapeutic applications of lytic phages Natural solution to antibiotic resistance: bacteriophages 'The Living Drugs'Phage therapy of Pseudomonas aeruginosa infection in a mouse burn wound model Experimental phage therapy against Staphylococcus aureus in mice Dynamics of success and failure in phage and antibiotic therapy in experimental infections Bacteriophage Procurement for Therapeutic Purposes Insights into Bacteriophage Application in Controlling Vibrio Species Co-therapy using lytic bacteriophage and linezolid: effective treatment in eliminating methicillin resistant Staphylococcus aureus (MRSA) from diabetic foot infections Isolation and characterization of φkm18p, a novel lytic phage with therapeutic potential against extensively drug resistant Acinetobacter baumannii Pseudomonas aeruginosa keratitis in mice: effects of topical bacteriophage KPP12 administration Encapsulation of Bacteriophage in Liposome Accentuates Its Entry in to Macrophage and Shields It from Neutralizing Antibodies Bacteriophage therapy of a Vibrio parahaemolyticus infection caused by a multiple-antibiotic-resistant O3:K6 pandemic clinical strain.Bacteria, phages and septicemia.Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials.Efficacy of bacteriophage therapy in a model of Burkholderia cenocepacia pulmonary infection.The Bacteriophage EF-P29 Efficiently Protects against Lethal Vancomycin-Resistant Enterococcus faecalis and Alleviates Gut Microbiota Imbalance in a Murine Bacteremia Model.Phage therapy--constraints and possibilities.Phage therapy: assessment of the efficacy of a bacteriophage isolated in the treatment of salmonellosis induced by Salmonella enteritidis in mice Uterine dysfunction in biglycan and decorin deficient mice leads to dystocia during parturition.Characterization of a unique glycosylated anchor endopeptidase that cleaves the LPXTG sequence motif of cell surface proteins of Gram-positive bacteria.Possible use of bacteriophages active against Bacillus anthracis and other B. cereus group members in the face of a bioterrorism threat.Finding alternatives to antibiotics.Phages limit the evolution of bacterial antibiotic resistance in experimental microcosms.Influence of environmental variables in the efficiency of phage therapy in aquaculture Using bacteriophages to reduce formation of catheter-associated biofilms by Staphylococcus epidermidis.European regulatory conundrum of phage therapy.Phage therapy is effective against infection by Mycobacterium ulcerans in a murine footpad model Experimental phage therapy in treating Klebsiella pneumoniae-mediated liver abscesses and bacteremia in mice Evaluation of a cocktail of three bacteriophages for biocontrol of Escherichia coli O157:H7.Use of genetically engineered phage to deliver antimicrobial agents to bacteria: an alternative therapy for treatment of bacterial infections.Application of bacteriophages to control intestinal Escherichia coli O157:H7 levels in ruminants.Efficacy and pharmacokinetics of bacteriophage therapy in treatment of subclinical Staphylococcus aureus mastitis in lactating dairy cattle Novel agents for the treatment of resistant Gram-positive infections.Bacteriophage-mediated control of a two-species biofilm formed by microorganisms causing catheter-associated urinary tract infections in an in vitro urinary catheter model In vitro and in vivo bacteriolytic activities of Escherichia coli phages: implications for phage therapy.Evaluation of the efficacy of a bacteriophage in the treatment of pneumonia induced by multidrug resistance Klebsiella pneumoniae in mice.Evolutionarily distinct bacteriophage endolysins featuring conserved peptidoglycan cleavage sites protect mice from MRSA infection.

P2860

Q21131139-CF8CDC94-87F2-47B6-8451-E26D355F16FE Q21131311-D70D5E16-66EC-48A7-9E53-0153E72B6622 Q22061798-5AE4FDD1-A0AC-45CF-B436-3D0953427B89 Q23920569-53AF6AB9-643D-49EE-9009-D3C925D5C2F2 Q24563742-F69894AE-B6C7-4534-9AD0-1B3ECFA4D7B3 Q24673374-CC3D167D-D700-47B6-95FD-03366B268F2A Q24685170-D34F1AD3-0FFD-4BDE-A51A-B4A694A75CB5 Q24803578-653370DC-E82A-4453-BB31-9AD6091DC386 Q26738479-1CF26043-B742-45CF-944A-BF62C15BD8A2 Q26739744-BE7C2DB6-EA94-4809-BA94-FE5CCD3FD1B1 Q28394377-DD56EFEF-450C-4D05-9298-58DD57864566 Q28484243-75DECAE6-7F2F-4EC6-A5A3-8688CA1177F5 Q28484466-DFB225EA-A1BE-4D35-940B-6A97633B752D Q28551599-0C9C4F34-1353-4891-8CF4-7B613F54A133 Q30359301-81099855-D5FD-45AA-8BE0-8C26B0455EE2 Q33314331-6044A015-92DB-4659-A150-56D40890AAAB Q33419859-AB6357B3-3A07-4C7B-AB21-F5370EFDB028 Q33622945-9A2B029D-715F-4B29-BC55-B0CC47BC7DB1 Q33652281-E93A81FE-5581-46C0-89A4-B53EBAF77C70 Q33667556-C7C97417-F776-40FE-AB2F-E1A11255AA0C Q33867400-6E08D7FC-30F9-4712-9D58-B16085A4CC5D Q34130533-D6BF4579-56F1-4C5C-A366-62DADBB22DD7 Q34153505-803B5D4D-C65E-456B-9CAD-3F4785A264AE Q34176948-17454386-C10B-4FE1-B945-B3E45FAAEB27 Q34426004-81896F7A-DC96-4123-B8F0-B6DD0487F295 Q34426663-3B3EFA58-7A55-4F8E-8C06-C0B4BFD0B724 Q34498214-225E0F2F-9B56-4814-A5BD-A2C36C870A2F Q34506458-A8E05AC1-F9EA-4FDA-AE99-AA819A3875C6 Q34700022-12AB9ED6-A68A-4567-8380-6066F4FD969B Q34702499-FB6E5142-AA50-45E7-AF23-33C0B480FEE9 Q34737858-30B83C7D-0DDD-45C6-A408-08F0F38B92B8 Q34777447-E38F79E7-3DB8-4D6B-874D-91511E2B0574 Q34885744-704004D4-5FC2-41AF-A86D-B527042FC4D6 Q34973928-B581FDDC-D1D4-43F8-970C-3C45A2DEE65E Q35023248-69927E23-2159-4039-8977-522076FD2B0B Q35056042-E16833D3-BB9B-45DA-BCD4-3895B4C39B89 Q35105990-2D5271DD-B5C7-46E9-9D47-AD0FFC36C7AD Q35124495-C5F3445C-90DD-4355-9CE8-27836E1F7D8B Q35296685-786977FE-422A-472C-8BB5-318F5575E02B Q35432724-59CBB59A-C7CA-4648-B78B-C4609962894B

P2860

Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium.

http://www.wikidata.org/entity/Q34116507

description

2002 nî lūn-bûn

@nan

2002 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Bacteriophage therapy rescues ...... esistant Enterococcus faecium.

@ast

Bacteriophage therapy rescues ...... esistant Enterococcus faecium.

@en

Bacteriophage therapy rescues ...... esistant Enterococcus faecium.

@nl

type

label

Bacteriophage therapy rescues ...... esistant Enterococcus faecium.

@ast

Bacteriophage therapy rescues ...... esistant Enterococcus faecium.

@en

Bacteriophage therapy rescues ...... esistant Enterococcus faecium.

@nl

prefLabel

Bacteriophage therapy rescues ...... esistant Enterococcus faecium.

@ast

Bacteriophage therapy rescues ...... esistant Enterococcus faecium.

@en

Bacteriophage therapy rescues ...... esistant Enterococcus faecium.

@nl

P1433

Q34116507-B24787D9-7043-4B01-9935-D7C40A67EB5D

P1476

Q34116507-73FD792F-4D0B-4561-A28F-8EAF47DBA588

P2093

Q34116507-1DEF6948-8423-4015-B0E1-459179B44609

Q34116507-60371DE0-ABE6-4B8C-BD1E-47FD18DC8A25

Q34116507-B9DFB248-13A7-40A7-87A5-8AC878421706

Q34116507-BB955BA1-BE30-48DF-BE89-CB30F1CE139D

Q34116507-BEA99F95-AF8B-464C-BB52-B4ACFBA4CE9E

Q34116507-C03E5D3A-9CD2-4969-BF13-76681DD6FA5D

Q34116507-C2E8634E-448A-445A-807D-30328994C365

P2860

Q34116507-0A37D301-76C2-4B82-BE3A-C3C0C9220AA9

Q34116507-0E7444D6-124A-4AA0-88E3-0061232DC7EB

Q34116507-146A516F-E67F-4A12-853C-310CFB19538B

Q34116507-20C6E036-731E-4EA9-B42A-BF8B94CFF22E

Q34116507-2659867F-4B11-40D7-93F8-AB47DCBC24D6

Q34116507-278B3DCA-0210-4068-ACDC-18E8108AE6C3

Q34116507-5E5C5E4A-6403-4DA3-A253-7A0D8B390444

Q34116507-7BED21B8-C46D-4A7A-A348-EBDCDEC7683F

Q34116507-82302047-E601-426E-A839-7B291DC7618F

Q34116507-BC11C30C-9505-4C31-90E8-E344DF1C223D

P304

Q34116507-9D18ADF7-51CD-4925-B9EC-5D27B49E9860

P31

Q34116507-5A4082E7-00ED-4E1D-8AC3-9B1F6A8780DB

P356

Q34116507-FD30CF89-358F-4B77-9044-7152C031D427

P407

Q34116507-643071C8-B498-4F8D-AC96-861780962380

P433

Q34116507-601D8BC2-3ADC-4C1F-85CC-3FEC126581F0

P478

Q34116507-80957AC3-550C-421A-8C4D-C27A1947C0C4

P50

Q34116507-FBF73289-61AD-413C-835E-FE6AA77310A6

P577

Q34116507-0E9DB5BB-6195-4E03-8180-F55364339F0B

P698

Q34116507-D0D29E98-901C-4D4E-B907-E5FB6B410B5F

P921

Q34116507-075D2D30-71D9-48DE-A9B8-39F005FB6D52

P932

Q34116507-86214124-D22F-467F-B9B7-709CCF475720

P356

IAI.70.1.204-210.2002

P1433

Infection and Immunity

P1476

Bacteriophage therapy rescues ...... esistant Enterococcus faecium.

@en

P2093

Andrei N Trostel

http://www.w3.org/2001/XMLSchema#string

Bradford Powell

http://www.w3.org/2001/XMLSchema#string

Brian Paul

http://www.w3.org/2001/XMLSchema#string

Carl R Merril

http://www.w3.org/2001/XMLSchema#string

Paul Washart

http://www.w3.org/2001/XMLSchema#string

Richard Carlton

http://www.w3.org/2001/XMLSchema#string

Sankar Adhya

http://www.w3.org/2001/XMLSchema#string

P2860

Phage therapy: past history and future prospects.

Vancomycin-resistant enterococcal infections.

Bacteriophage prevents destruction of skin grafts by Pseudomonas aeruginosa.

Long-circulating bacteriophage as antibacterial agents

Bacteriophages show promise as antimicrobial agents.

Bacteriophage therapy and prophylaxis: rediscovery and renewed assessment of potential.

Treatment of experimental infections of mice with bacteriophages.

Fate of bacteriophage lambda in non-immune germ-free mice.

Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics.

Phage therapy--advantages over antibiotics?

P304

204-210

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/IAI.70.1.204-210.2002

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

70

http://www.w3.org/2001/XMLSchema#string

P50

Biswajit Biswas

P577

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11748184

http://www.w3.org/2001/XMLSchema#string

P921

P932

127648

http://www.w3.org/2001/XMLSchema#string